Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B

Background: In the GLOBE trial, telbivudine demonstrated superior efficacy to lamivudine at 2 years in patients with chronic hepatitis B (CHB). Aims: To investigate the long-term efficacy and safety of telbivudine in the telbivudine-treated cohort from the GLOBE trial. Methods: Virological and bioch...

Saved in:

書目詳細資料
Main Authors:	Gane E., Wang Y., Liaw Y., Hou J., Thongsawat S., Wan M., Moon Y., Jia J., Chao Y., Niu J., Leung N., Samuel D., Hsu C., Bao W., Lopez P., Avila C.
格式:	雜誌
出版:	2017
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953315167&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43070
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
由: Edward J. Gane, et al.
出版: (2018)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
由: Y. Wang, et al.
出版: (2018)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
由: Wang Y., et al.
出版: (2014)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
由: Y. Wang, et al.
出版: (2018)

Telbivudine versus lamivudine in patients with chronic hepatitis B
由: Ching Lung Lai, et al.
出版: (2018)

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
由: Zeuzem, S., et al.
出版: (2016)

Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial
由: Chan, H.L.Y., et al.
出版: (2016)

Telbivudine: A hepatitis B-specific antiviral
由: Lim, S.G.
出版: (2011)

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
由: Marcellin Patrick, et al.
出版: (2016)

Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: Pharmacodynamic implications
由: Zhou, X.-J., et al.
出版: (2016)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategy
由: Teerha Piratvisuth, et al.
出版: (2018)

Ragaman Genetik Gen Polimerase Virus Hepatitis B Pada Pasien Hepatitis B Kronik dengan Pengobatan Telbivudine
由: Mastutik, Gondo, et al.
出版: (2015)

Evaluation of one-year lamivudine and telbivudine therapy on chronic hepatitis b patients: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
由: Ummi Maimunah, et al.
出版: (2019)

Evaluation of one year lamivudine and telbivudine therapy on chronic hepatitis b patient: Based on biochemical, virological and fibrosis status in dr. soetomo general hospital
由: Ummi Maimunah, et al.
出版: (2019)

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
由: Colvin,R.A., et al.
出版: (2015)

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
由: Chang, T.-T., et al.
出版: (2016)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: Lau G.K.K., et al.
出版: (2014)

Analisis Gen P Virus Hepatitis B (VHB) pada Serum Penderita Hepatitis B Kronik yang mendapat pengobatan Telbivudine dikaitkan dengan jumlah muatan virus sebelum pengobatan
由: Mastutik, Gondo, et al.
出版: (2010)

Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
由: Soon, D.K.W., et al.
出版: (2014)

The economics of treating chronic hepatitis B in Asia
由: Dan, Y.Y., et al.
出版: (2011)

Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B
由: You, H, et al.
出版: (2020)

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
由: Yun Fan Liaw, et al.
出版: (2018)

Applicability of cost-effectiveness analysis to management of chronic hepatitis B
由: Dan, Y.Y., et al.
出版: (2011)

EVALUASI PEMBERIAN TERAPI LAMIVUDIN DAN TELBIVUDIN PADA PASIEN HEPATITIS B KRONIS DI RSUD DR. SOETOMO SURABAYA PADA PERIODE TERAPI 2014 – 2015
由: Erik Geraldus Edison, NIM011511133143
出版: (2018)

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen
由: Wang, Y.M., et al.
出版: (2014)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
由: Kumthip K., et al.
出版: (2014)

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
由: Hadziyannis, S.J., et al.
出版: (2014)

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients
由: Patel K., et al.
出版: (2017)

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B
由: Tan, A.T., et al.
出版: (2011)

Prolonged Ambulatory Oesophageal pH and Pressure Recording in Healthy Adults in Singapore
由: Ho, K.Y., et al.
出版: (2014)

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
由: Kao J., et al.
出版: (2017)

Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
由: Ahn, S.H., et al.
出版: (2011)

Non-invasive models for predicting histology in patients with chronic hepatitis B
由: Wai, C.-T., et al.
出版: (2012)

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
由: Marcellin, P., et al.
出版: (2014)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
由: Kattareeya Kumthip, et al.
出版: (2018)

Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
由: Kattareeya Kumthip, et al.
出版: (2018)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: George K.K. Lau, et al.
出版: (2018)

Co-encapsulation of bFGF-loaded microspheres and hepatocytes in microbeads for prolonging hepatic pre-transplantation
由: Saimok W.
出版: (2023)

Thrombocytopenia in Chronic Hepatitis C
由: Arvi Dian Prasetia Nurwidda, et al.
出版: (2017)

Mercury, chronic hepatitis and hepatoma
由: Viroj Wiwnaitkit, et al.
出版: (2018)